Molecular Partners AG Financial Overview
Molecular Partners AG's market cap is currently CHF144.54M. The company's EPS TTM is CHF-0.55; its P/E ratio is -2.17; Molecular Partners AG is scheduled to report earnings on August 25, 2025, and the estimated EPS forecast is CHF-0.31. See an overview of income statement, balance sheet, and cash flow financials.
